PHASE-II TRIAL OF 1,2-DIAMINOCYCLOHEXANE-(4-CARBOXYPHTHALATO) PLATINUM(II) IN PATIENTS WITH REFRACTORY GERM-CELL TUMORS

被引：0
|
作者：
CHUN, H [1 ]
BOSL, GJ [1 ]
GOLBEY, RB [1 ]
机构：
[1] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021
来源：
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：459 / 460
页数：2
相关论文
共 50 条
  • [41] CARBOPLATIN IN ADVANCED, REFRACTORY GERM-CELL NEOPLASMS - A PHASE-II EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
    TRUMP, DL
    ELSON, P
    BRODOVSKY, H
    VOGL, SE
    CANCER TREATMENT REPORTS, 1987, 71 (10): : 989 - 990
  • [42] SALVAGE CHEMOTHERAPY OF NONSEMINOMATOUS GERM-CELL TUMORS - PHASE-II TRIAL OF AN ETOPOSIDE, IFOSFAMIDE AND HIGH-DOSE CISPLATIN (VLHP) COMBINATION
    RIBRAG, V
    DROZ, JP
    BOULEUC, C
    THEODORE, C
    GHOSN, M
    PICO, JL
    AZAB, M
    OSTRONOFF, M
    HAYAT, M
    PRESSE MEDICALE, 1990, 19 (27): : 1263 - 1266
  • [43] PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH PLATINUM-REFRACTORY ADVANCED OVARIAN-CANCER
    FRANCIS, P
    SCHNEIDER, J
    HANN, L
    BALMACEDA, C
    BARAKAT, R
    PHILLIPS, M
    HAKES, T
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) : 2301 - 2308
  • [44] Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors
    Kawahara, Takashi
    Kawai, Koji
    Kojima, Takahiro
    Nagumo, Yoshiyuki
    Sakka, Shotarou
    Kandori, Shuya
    Negoro, Hiromitsu
    Mathis, Bryan J.
    Maruo, Kazushi
    Miura, Koji
    Sakamoto, Noriaki
    Shinohara, Nobuo
    Yamashita, Shinichi
    Yonemori, Kan
    Kishida, Takeshi
    Ukimura, Osamu
    Nishimura, Kazuo
    Kobayashi, Yasuyuki
    Nishiyama, Hiroyuki
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (07) : 741 - 747
  • [45] PLACEBO CONTROLLED PHASE-I PHASE-II STUDY OF SUBCUTANEOUS GM-CSF IN PATIENTS WITH GERM-CELL TUMORS UNDERGOING CHEMOTHERAPY
    JOST, LM
    PICHERT, G
    STAHEL, RA
    ANNALS OF ONCOLOGY, 1990, 1 (06) : 439 - 442
  • [46] PHASE-II TRIAL OF AZIRIDINYLBENZOQUINONE (AZQ) IN PATIENTS WITH REFRACTORY LYMPHOMA
    MCLAUGHLIN, P
    CABANILLAS, F
    BEDIKIAN, AY
    BODEY, GP
    CANCER TREATMENT REPORTS, 1983, 67 (05): : 507 - 508
  • [47] Phase II clinical trial of oxaliplatin and bevacizumab in refractory metastatic germ cell tumors (GCT).
    Jain, A.
    Brames, M. J.
    Vaughn, D. J.
    Einhorn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] A PHASE-II TRIAL OF EARLY INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF POOR PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS
    DROZ, JP
    PICO, JL
    GHOSN, M
    KRAMAR, A
    REY, A
    OSTRONOFF, M
    BAUME, D
    BULLETIN DU CANCER, 1992, 79 (05) : 497 - 507
  • [49] Phase II study of everolimus in refractory testicular germ cell tumors
    Mego, Michal
    Svetlovska, Daniela
    Miskovska, Vera
    Obertova, Jana
    Palacka, Patrik
    Rajec, Jan
    Sycova-Mila, Zuzana
    Chovanec, Michal
    Rejlekova, Katarina
    Zuzak, Peter
    Ondrus, Dalibor
    Spanik, Stanislav
    Reckova, Maria
    Mardiak, Jozef
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (03) : 122.e17 - 122.e22
  • [50] A PHASE-II TRIAL OF CARBOPLATIN IN PATIENTS WITH ADVANCED APUD TUMORS
    SALTZ, L
    LAUWERS, G
    WISEBERG, J
    KELSEN, D
    CANCER, 1993, 72 (02) : 619 - 622
12345